Download FREE Report Sample
Download Free sampleThe global Urokinase market was valued at 38.72 Million USD in 2021 and will grow with a CAGR of 6.3% from 2021 to 2027, based on Research newly published report.
The prime objective of Urokinase Market is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, Urokinase Market covers market segmentation by major market vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.Major players in the industry are NDPHARM, Wanhua Biochem and LIVZON, which accounted for 22.35 percent, 10.11 percent and 21.86 percent of revenue in 2019, respectively. According to the region, China`s income is the highest, reaching 82.57% in 2019.
By Market Vendors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy